ori-image3
ori-image2
ori-image1

The future of Cell and Gene Therapy manufacturing just got brighter

Enter a new era of widespread access to lifesaving treatments

ori-image3
ori-image2
ori-image1

Enabling patient access to lifesaving treatmentsThat's our mission

With the revolutionary Ori manufacturing platform, it will be possible to increase throughput, improve quality and decrease costs in Cell and Gene Therapy (CGT) manufacturing, so that more patients can experience life's most precious moments with the people they love.

ori-hero-section3

Designed by experts with decades of Cell and Gene Therapy experience

Ori Biotech is a London- and New Jersey-based innovator in CGT manufacturing that has developed a proprietary, bespoke and flexible manufacturing platform, which enables patient access to a new generation of personalised, lifesaving treatments.

By fully automating and standardising CGT manufacturing in a closed platform, Ori offers therapeutics developers the opportunity to seamlessly scale from pre-clinical process development to commercial scale manufacturing.

So complex manufacturing challenges can be put where they belong – in the past.

Meet the team

Ori is pioneering the future of CGT manufacturing technology, bringing together the most innovative minds in the field who are truly passionate about helping to manufacture brighter futures.

Ori Biotech Leadership Team UK
  • Leadership
  • Board
  • Advisors
  • Farlan Veraitch, PhD

    Co-founder and Chief Scientific Officer

  • Jason C. Foster, MBA Chief Executive Officer and Executive Director, Ori Biotech

    Jason C. Foster, MBA

    Chief Executive Officer and Executive Director

  • Jason Jones, Chief Business Officer, Ori Biotech

    Jason Jones

    Chief Business Officer

  • Kevin Gordon, Chief Data and Operating Officer Ori Biotech

    Kevin Gordon

    Chief Data and Operating Officer

  • Stuart Milne PHD, Chief Technology Officer Ori Biotech

    Stuart Milne, PhD

    Chief Technology Officer

  • William Raimes, PhD Head of Process Development, Ori Biotech

    William Raimes, PhD

    Head of Process Development

  • Arman Amini, PhD Head of Cell Processing, Ori Biotech

    Arman Amini, PhD

    Head of Cell Processing

  • Andrew Gawman, Global Finance Director at Ori Biotech

    Andrew Gawman

    Global Finance Director

  • Moeko Saito, Scientific Project Manager at Ori Biotech

    Moeko Saito

    Scientific Project Manager

  • Thomas Heathman, Ori Biotech Team

    Thomas Heathman, PhD

    VP Commercial Operations

  • Lee Unroe, VP Marketing Ori Biotech

    Lee Unroe

    VP Marketing

  • David Smith VP Technical Operations at Ori Biotech

    David Smith

    VP Technical Operations

Close

Farlan Veraitch, PhD

Co-founder and Chief Scientific Officer

Farlan is an internationally-recognised expert on CGT manufacturing, with over a decade of experience as a leading academic at University College London.

Our partners

Ori is building partnerships with the most forward-thinking organisations in the industry.

Latest News & Insights

Discover how we're driving innovation in CGT manufacturing.

Ori Biotech
Ori Biotech Press Releases

Ori Biotech Appoints New Senior Management Roles and Further Expands Scientific Teams

Read more
Ori Spotlight Podcast - Robert Preti

Ori Spotlight Episode Eight – Robert Preti, PhD, Strategic Advisory Board, Ori Biotech

Read more
Genetic Engineering & Biotechnology News - Digitisation in CGT
Ori Biotech News

Digital Tech Vital for Innovation in Cell/Gene Therapy Manufacturing

genengnews.com